These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6242775)

  • 1. Problems and safety of continuous subcutaneous insulin infusion.
    Home PD; Marshall SM
    Diabet Med; 1984 May; 1(1):41-4. PubMed ID: 6242775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ketoacidosis during insulin pump therapy--an acceptable risk?].
    Walter H; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):722-5. PubMed ID: 2496966
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Continuous subcutaneous insulin infusion].
    Ito H; Kanatsuka A
    Nihon Rinsho; 1997 Nov; 55 Suppl():267-72. PubMed ID: 9434479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetic ketoacidosis during insulin pump therapy].
    Walter H; Günther A; Timmler R; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):706-8. PubMed ID: 2496965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump therapy in children with type 1 diabetes: the dark side of the moon.
    Scaramuzza AE; Dell'Acqua M; Macedoni M; Zuccotti GV
    J Diabetes Sci Technol; 2013 Jul; 7(4):1095-7. PubMed ID: 23911194
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic ketoacidosis caused by exposure of insulin to low temperature.
    Minuto N; Tambroni B; Vannati M; Emmanuele V; Russo C; Lorini R; d'Annunzio G
    Diabetes Technol Ther; 2010 Sep; 12(9):745-6. PubMed ID: 20687866
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion.
    Peden NR; Braaten JT; McKendry JB
    Diabetes Care; 1984; 7(1):1-5. PubMed ID: 6423352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
    Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
    Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pumps.
    Torrance T; Franklin V; Greene S
    Arch Dis Child; 2003 Nov; 88(11):949-53. PubMed ID: 14612350
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.
    Bending JJ; Pickup JC; Keen H
    Am J Med; 1985 Dec; 79(6):685-91. PubMed ID: 3934967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factitious self-manipulation of the external insulin pump in adolescents with Type 1 diabetes.
    Moreau F; Spizzo H; Bursztejn C; Berthoux V; Agin A; Pinget M; Pasquali JL; Kessler L
    Diabet Med; 2011 May; 28(5):623-4. PubMed ID: 21303404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetic ketoacidosis by exposure of insulin pump to heat and sunlight].
    Pryce R
    Praxis (Bern 1994); 2009 May; 98(10):543-5. PubMed ID: 19424950
    [No Abstract]   [Full Text] [Related]  

  • 16. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New modes of insulin administration: do they have a role in clinical diabetes?
    Rizza RA
    Ann Intern Med; 1986 Jul; 105(1):126-9. PubMed ID: 3087254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks].
    Sonnenberg GE; Spraul M; Chantelau EA; Berger M
    Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight.
    Pryce R
    BMJ; 2009 Jan; 338():a2218. PubMed ID: 19124546
    [No Abstract]   [Full Text] [Related]  

  • 20. Mismanagement of infusion pumps.
    Sonnenberg GE; Chantelau E; Berger M
    Diabetes Care; 1982; 5(2):145. PubMed ID: 6927726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.